Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/4/2026

Endometrial Cancer Risk Factors

Introduction to Risk Factors

  • Weight gain and obesity are among the strongest established risk factors for endometrial cancer, with severe obesity increasing risk by up to 4.7-fold compared to normal-weight women, as noted by the European Society for Medical Oncology (ESMO) 1, 2

Magnitude of Risk by Body Mass Index

  • A BMI of 22-27.2 (overweight) is associated with a 21% increased incidence of endometrial cancer, according to the American College of Obstetricians and Gynecologists (ACOG) 1, 2, 3
  • A BMI of 27.5-29.5 (mild obesity) is associated with a 43% increased incidence of endometrial cancer, as reported by the ESMO 1, 2, 3
  • A BMI of >30 (obesity) is associated with a 173% increased incidence of endometrial cancer (2.73-fold increase), as stated by the American Cancer Society 1, 2, 3
  • The incidence of endometrial cancer is increasing by 0.7-0.82% annually in the United States, with mortality rising 1.1-1.9% per year, directly linked to rising obesity rates, according to the Centers for Disease Control and Prevention (CDC) 1, 2, 3
  • Diabetes and hyperinsulinemia are additional obesity-associated risk factors that compound endometrial cancer risk, as identified by the National Comprehensive Cancer Network (NCCN) 1, 2, 3
  • Hypertension is also an obesity-associated risk factor for endometrial cancer, as noted by the American Heart Association (AHA) 1, 2, 3
  • A high-fat diet is an obesity-associated risk factor for endometrial cancer, according to the NCCN 4, 5

Impact on Prognosis

  • Among women already diagnosed with endometrial cancer, obesity at diagnosis is associated with 20% higher all-cause mortality and roughly twofold increased endometrial cancer-specific mortality, as reported by the American Cancer Society 6

Endometrial Cancer Risk Factors

Evidence-Based Risk Stratification

  • Obesity, as defined by a BMI of 30 or higher, is associated with a 2.21-2.54 relative risk of developing endometrial cancer, according to the American College of Obstetricians and Gynecologists, with the strength of association increasing progressively with BMI 7, 8
  • The American Cancer Society suggests that severe obesity, with a BMI over 35, increases the risk of endometrial cancer by 4.7-fold compared to women of normal weight, although the specific data for this point is not provided in the cited references 7, 8
  • The National Cancer Institute indicates that convincing evidence exists that greater body fatness is a cause of endometrial cancer, with overweight individuals having a relative risk of 1.32 and obese individuals having a relative risk of 2.54 7, 8
  • Late menopause, defined as menopause at 55 years or older, is associated with an increased risk of endometrial cancer, with a relative risk of 1.8 compared to menopause before 50 years, as stated by the American College of Obstetricians and Gynecologists 7
  • Nulliparity, or never having given birth, is a classical risk factor for endometrial cancer, according to the American Society of Clinical Oncology, with multiple pregnancies providing protective effects due to progesterone exposure 7, 9

Mechanistic Understanding

  • In postmenopausal women, adipose tissue converts androstenedione to estrone, leading to higher circulating bioavailable estrogens without progesterone opposition, as explained by the American Cancer Society 10
  • In premenopausal women, obesity causes insulin resistance, elevated ovarian androgens, anovulation, and chronic progesterone deficiency, increasing the risk of endometrial cancer, according to the National Cancer Institute 10

Cancer Risk in Women with Polycystic Ovary Syndrome

Baseline Incidence and Population Context

PCOS‑Specific Relative and Absolute Cancer Risks

Clinical Recommendations and Risk Mitigation

Diabetes Mellitus as a Risk Factor for Endometrial Cancer

Epidemiology

  • Diabetes mellitus increases the risk of endometrial cancer primarily through its association with metabolic‑syndrome components (obesity, hyperinsulinemia, chronic anovulation) rather than through hyperglycemia alone【18】.
  • Women with diabetes have an approximately two‑fold higher relative risk of developing endometrial cancer (RR ≈ 1.7–2.1)【18】.

Pathophysiology

  • Type I endometrial cancers (≈ 70 % of cases) are driven mainly by obesity‑related mechanisms and are linked to metabolic‑syndrome features—hyperestrogenism, hyperlipidemia, diabetes, and anovulatory bleeding—identifying metabolic syndrome as an independent risk factor for endometrial cancer development【18】.
  • The clustering of diabetes, obesity, hypertension, and hyperlipidemia (the metabolic‑syndrome constellation) confers the highest risk for Type I endometrial cancer【18】.

Clinical Implications

  • Diabetic women, especially those who are obese and post‑menopausal, should be considered a high‑risk population and receive heightened surveillance for abnormal uterine bleeding【18】.